Matthew Thompson
Vorstandsvorsitzender bei ENDOLOGIX, INC.
Vermögen: - $ am 31.05.2024
Profil
Matthew Thompson is the founder of the British Society of Endovascular Therapy Ltd.
(founded in 2004).
He is currently the President, Chief Executive Officer & Director at Endologix LLC, the Chief Executive Officer at TriVascular, Inc., an Independent Director at Vivos Therapeutics, Inc., the President of The Vascular Society, and a Professor at Stanford School of Medicine.
Previously, he was a Professor of Vascular Surgery at St. George's University of London and a Professor at St Georges Vascular Institute.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VIVOS THERAPEUTICS, INC.
-.--% | 26.03.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
| 23.12.2022 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Matthew Thompson
| Unternehmen | Position | Beginn |
|---|---|---|
| ENDOLOGIX, INC. | Vorstandsvorsitzender | 11.11.2021 |
| VIVOS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.06.2020 |
The Vascular Society
 The Vascular Society Investment Trusts/Mutual FundsMiscellaneous The Vascular Society operates as a grant-making organization to provide education and training. The non-profit company is based in London, UK. | Präsident | 01.01.2018 |
| Stanford School of Medicine | Corporate Officer/Principal | 01.01.2017 |
TriVascular, Inc.
 TriVascular, Inc. Medical SpecialtiesHealth Technology TriVascular, Inc. develops and manufactures medical devices. It provides devices and procedures for treating abdominal aortic aneurysms and endovascular grafts. The company was founded by Michael V. Chobotov, Robert G. Whirley, and Joseph W. Humphrey in 1998 and is headquartered in Irvine, CA. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Matthew Thompson
| Unternehmen | Position | Ende |
|---|---|---|
| St. George's University of London | Corporate Officer/Principal | 01.01.2016 |
| St Georges Vascular Institute | Corporate Officer/Principal | 01.01.2016 |
| British Society of Endovascular Therapy Ltd. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VIVOS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Endologix LLC
 Endologix LLC Medical SpecialtiesHealth Technology Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA. | Health Technology |
TriVascular, Inc.
TriVascular, Inc. Medical SpecialtiesHealth Technology TriVascular, Inc. develops and manufactures medical devices. It provides devices and procedures for treating abdominal aortic aneurysms and endovascular grafts. The company was founded by Michael V. Chobotov, Robert G. Whirley, and Joseph W. Humphrey in 1998 and is headquartered in Irvine, CA. | Health Technology |
The Vascular Society
The Vascular Society Investment Trusts/Mutual FundsMiscellaneous The Vascular Society operates as a grant-making organization to provide education and training. The non-profit company is based in London, UK. | Miscellaneous |
| British Society of Endovascular Therapy Ltd. |
